Reactivation of histoplasmosis after treatment with infliximab

被引：78

作者：

Nakelchik, M ^{[1
]}

Mangino, JE ^{[1
]}

机构：

[1] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA

来源：

AMERICAN JOURNAL OF MEDICINE | 2002年 / 112卷 / 01期

关键词：

D O I：

10.1016/S0002-9343(01)00945-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：78 / 78

页数：1

共 7 条

[1]

Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636

[2]

*CENT INC, 1999, REM INFL

[3] RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS [J].

ELLIOTT, MJ ;

MAINI, RN ;

FELDMANN, M ;

KALDEN, JR ;

ANTONI, C ;

SMOLEN, JS ;

LEEB, B ;

BREEDVELD, FC ;

MACFARLANE, JD ;

BIJL, H ;

WOODY, JN .

LANCET, 1994, 344 (8930) :1105-1110

[4] Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation [J].

Jacobs, M ;

Marino, MW ;

Brown, N ;

Abel, B ;

Bekker, LG ;

Quesniaux, VJF ;

Fick, L ;

Ryffel, B .

LABORATORY INVESTIGATION, 2000, 80 (06) :901-914

[5]

Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO

[6]

2-W

[7]

Szatmáry Z, 1999, NEOPLASMA, V46, P257

← 1 →